Your browser doesn't support javascript.
loading
Pharmacokinetics, Safety and Tolerability of Chiglitazar, A Novel Peroxisome Proliferator-Activated Receptor (PPAR) Pan-Agonist, in Healthy Chinese Volunteers: A Phase I Study.
Xu, Hong-Rong; Zhang, Jin-Wen; Chen, Wei-Li; Ning, Zhi-Qiang; Li, Xue-Ning.
Affiliation
  • Xu HR; Department of Clinical Pharmacology, ZhongShan Hospital, Fudan University, No. 180, Fenglin Road, Xuhui District, Shanghai, 200032, People's Republic of China.
  • Zhang JW; Chipscreen Biosciences Co., Ltd., Bio-Incubator Suite 2-601, Shenzhen Hi-Tech Industrial Park, Nanshan District, Shenzhen, 518057, Guangdong, People's Republic of China.
  • Chen WL; Department of Clinical Pharmacology, ZhongShan Hospital, Fudan University, No. 180, Fenglin Road, Xuhui District, Shanghai, 200032, People's Republic of China.
  • Ning ZQ; Chipscreen Biosciences Co., Ltd., Bio-Incubator Suite 2-601, Shenzhen Hi-Tech Industrial Park, Nanshan District, Shenzhen, 518057, Guangdong, People's Republic of China.
  • Li XN; Department of Clinical Pharmacology, ZhongShan Hospital, Fudan University, No. 180, Fenglin Road, Xuhui District, Shanghai, 200032, People's Republic of China. li.xuening@zs-hospital.sh.cn.
Clin Drug Investig ; 39(6): 553-563, 2019 Jun.
Article in En | MEDLINE | ID: mdl-31037611

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Propionates / Carbazoles / Peroxisome Proliferator-Activated Receptors Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: Clin Drug Investig Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2019 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Propionates / Carbazoles / Peroxisome Proliferator-Activated Receptors Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: Clin Drug Investig Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2019 Type: Article